Study: Bivalent Booster Enhances Omicron Immunity After All
Not too long ago two studies came out on the new bivalent booster, one from Columbia and one from people at Harvard . Both showed that, in the words of the Columbia authors, bivalent mRNA vaccine targeting Omicron BA.4/BA.5 and an ancestral SARS-CoV-2 strain did not induce superior neutralizing antibody responses in humans, at the time period tested, compared to the original monovalent vaccine formulation. At the time experts noted that both of these were based on very small samples. They said let's wait for some more robust findings to come out. Now new results have been jointly released by Pfizer and Moderna. Their study has a larger sample (n = 114) that was stratified to include both 18-55 and over 65 age groups, both of whom got the new bivalent booster. There was also a comparison group of people over 65 who got another dose of the old vaccines. They measured everyone's antibody levels before, and found them to be the same. Then they looked that the levels one...